Segall Bryant & Hamill LLC Invests $881,000 in VanEck Biotech ETF $BBH

Segall Bryant & Hamill LLC acquired a new position in VanEck Biotech ETF (NASDAQ:BBH) during the 1st quarter, HoldingsChannel reports. The fund acquired 4,590 shares of the company’s stock, valued at approximately $881,000.

A number of other institutional investors and hedge funds have also bought and sold shares of BBH. Empowered Funds LLC acquired a new position in VanEck Biotech ETF during the 4th quarter worth about $38,000. Flagship Harbor Advisors LLC acquired a new stake in shares of VanEck Biotech ETF in the fourth quarter valued at about $47,000. Allworth Financial LP increased its stake in shares of VanEck Biotech ETF by 255.0% in the fourth quarter. Allworth Financial LP now owns 426 shares of the company’s stock valued at $81,000 after buying an additional 306 shares during the period. Fifth Third Bancorp acquired a new stake in shares of VanEck Biotech ETF in the first quarter valued at about $127,000. Finally, Huntington National Bank bought a new position in shares of VanEck Biotech ETF during the fourth quarter worth about $132,000. 32.05% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other VanEck Biotech ETF news, major shareholder Sardar Biglari sold 2,749 shares of the firm’s stock in a transaction that occurred on Thursday, July 16th. The shares were sold at an average price of $16.70, for a total transaction of $45,908.30. Following the completion of the transaction, the insider owned 3,549,961 shares in the company, valued at approximately $59,284,348.70. This trade represents a 0.08% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Over the last three months, insiders have sold 10,493 shares of company stock worth $175,335.

VanEck Biotech ETF Stock Up 1.1%

VanEck Biotech ETF stock opened at $210.38 on Thursday. The stock’s 50 day moving average is $198.68 and its 200 day moving average is $193.21. VanEck Biotech ETF has a one year low of $156.45 and a one year high of $212.54.

VanEck Biotech ETF Profile

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.